Çınar BP - Search Results

1

Oxytocin provides protection against diabetic polyneuropathy in rats.

Erbas O, Taşkıran D, Oltulu F, Yavaşoğlu A, Bora S, Bilge O, Çınar BP, Peker G. Erbas O, et al. Among authors: cinar bp. Neurol Res. 2017 Jan;39(1):45-53. doi: 10.1080/01616412.2016.1249630. Epub 2016 Nov 24. Neurol Res. 2017. PMID: 27881053

2

Neuroprotective effects of octreotide on diabetic neuropathy in rats.

Solmaz V, Çınar BP, Yiğittürk G, Özlece HK, Avni Eroglu H, Tekatas A, Erbaş O, Taşkıran D. Solmaz V, et al. Among authors: cinar bp. Biomed Pharmacother. 2017 May;89:468-472. doi: 10.1016/j.biopha.2017.02.027. Epub 2017 Feb 27. Biomed Pharmacother. 2017. PMID: 28249248

3

The neuroprotective effect of erythropoietin on experimental Parkinson model in rats.

Erbaş O, Çınar BP, Solmaz V, Çavuşoğlu T, Ateş U. Erbaş O, et al. Among authors: cinar bp. Neuropeptides. 2015 Feb;49:1-5. doi: 10.1016/j.npep.2014.10.003. Epub 2014 Oct 30. Neuropeptides. 2015. PMID: 25464888

4

Exenatide reduces TNF-α expression and improves hippocampal neuron numbers and memory in streptozotocin treated rats.

Solmaz V, Çınar BP, Yiğittürk G, Çavuşoğlu T, Taşkıran D, Erbaş O. Solmaz V, et al. Among authors: cinar bp. Eur J Pharmacol. 2015 Oct 15;765:482-7. doi: 10.1016/j.ejphar.2015.09.024. Epub 2015 Sep 16. Eur J Pharmacol. 2015. PMID: 26386291

5

Inhibitor effect of paricalcitol in rat model of pentylenetetrazol-induced seizures.

Uyanıkgil Y, Solmaz V, Çavuşoğlu T, Çınar BP, Çetin EÖ, Sur HY, Erbaş O. Uyanıkgil Y, et al. Among authors: cinar bp. Naunyn Schmiedebergs Arch Pharmacol. 2016 Oct;389(10):1117-22. doi: 10.1007/s00210-016-1273-z. Epub 2016 Jul 20. Naunyn Schmiedebergs Arch Pharmacol. 2016. PMID: 27438482

6

The reducing effect of agomelatine on pentylenetetrazol-induced convulsions.

Demirel EA, Erdoğan MA, Cinar BP, Erbas O. Demirel EA, et al. Among authors: cinar bp. Biol Futur. 2019 Dec;70(4):336-340. doi: 10.1556/019.70.2019.38. Epub 2019 Dec 1. Biol Futur. 2019. PMID: 34554538

7

Cognitive dysfunction in patients with multiple sclerosis treated with first-line disease-modifying therapy: a multi-center, controlled study using the BICAMS battery.

Cinar BP, Kösehasanoğulları G, Yigit P, Ozakbas S. Cinar BP, et al. Neurol Sci. 2017 Feb;38(2):337-342. doi: 10.1007/s10072-016-2775-7. Epub 2016 Nov 24. Neurol Sci. 2017. PMID: 27885448 Clinical Trial.

8

Clinical-epidemiological and radiological characteristics of stroke patients: A multicentre study.

Kunt R, Çınar BP, Yüksel B, Güllüoğlu H, Sayılır İ, Çeliker Uslu S, Özaydın Göksu E, Bülbül NG, Yıldız B, Öz D, Keskin AO, Korucu O, Akpınar ÇK, Solmaz V, Akpınar M, Altunç FZ, Elmas Z, Büyükuysal Ç, Ekici M, Güvendi G. Kunt R, et al. Among authors: cinar bp. Int J Clin Pract. 2021 Dec;75(12):e14963. doi: 10.1111/ijcp.14963. Epub 2021 Oct 24. Int J Clin Pract. 2021. PMID: 34626055

9

Intrathecal IgM index correlates with a severe disease course in multiple sclerosis: Clinical and MRI results.

Ozakbas S, Cinar BP, Özcelik P, Baser H, Kosehasanoğullari G. Ozakbas S, et al. Among authors: cinar bp. Clin Neurol Neurosurg. 2017 Sep;160:27-29. doi: 10.1016/j.clineuro.2017.05.026. Epub 2017 Jun 1. Clin Neurol Neurosurg. 2017. PMID: 28622533

10

Monthly methylprednisolone in combination with interferon beta or glatiramer acetate for relapsing-remitting multiple sclerosis: A multicentre, single-blind, prospective trial.

Ozakbas S, Cinar BP, Kosehasanoğullari G, Kahraman T, Oz D, Kursun BB. Ozakbas S, et al. Among authors: cinar bp. Clin Neurol Neurosurg. 2017 Sep;160:69-72. doi: 10.1016/j.clineuro.2017.06.016. Epub 2017 Jun 27. Clin Neurol Neurosurg. 2017. PMID: 28689102 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

19 results

Search Page